Hearing evaluation in patients with chronic renal failure

Objective: To evaluate hearing threshold and the severity of hearing loss at different frequencies in patients with chronic renal failure (CRF), and to analyze the role of duration of disease on hearing threshold in patients of CRF by measuring pure-tone audiometry (PTA) and distortion-product otoac...

Full description

Bibliographic Details
Main Authors: Evis Bendo, Margarita Resuli, Spiros Metaxas
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-03-01
Series:Journal of Acute Disease
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2221618914600834
id doaj-58583473da6a420f97a87024ff4cf9cc
record_format Article
spelling doaj-58583473da6a420f97a87024ff4cf9cc2020-11-24T21:40:02ZengWolters Kluwer Medknow PublicationsJournal of Acute Disease2221-61892015-03-0141515310.1016/S2221-6189(14)60083-4Hearing evaluation in patients with chronic renal failureEvis Bendo0Margarita Resuli1Spiros Metaxas2ENT Department, Mother Tereza University Hospital, Tirane, AlbaniaEnternal Diseases Department, Mother Tereza University Hospital, Tirane, AlbaniaENT Department, Papageorgiou Hospital, Thessaloniki, GreeceObjective: To evaluate hearing threshold and the severity of hearing loss at different frequencies in patients with chronic renal failure (CRF), and to analyze the role of duration of disease on hearing threshold in patients of CRF by measuring pure-tone audiometry (PTA) and distortion-product otoacoustic emission (DPOAE). Methods: There were analysed 61 subjects (122 ears) from which 12 were patients starting hemodialise (A), 24 subjects were patients undergoing hemodialise over a year (B), 15 subjects were patients undergoing conservative treatment (C) and 10 controls (D). We did hearing evaluation by testing them using tympanometry, PTA and DPOAEs. Other parameters (blood pressure, body weight, blood chemistries) were also evaluated. Results: It was found a severe high-frequency hearing loss among patients with CRF comparing to the control group. Duration on haemodialysis treatment does not seem to have a significant impact on the incidence of hearing loss, although the method of treatment may influence the impact of the disease on hearing. Hearing loss among patients with CRF seemed to deteriorate further a year after the first evaluation. Conclusions: DPOAE raised the percentages of detection of SNHL indicating that it is a better technique than the conventional PTA for evaluation of hearing acuity.http://www.sciencedirect.com/science/article/pii/S2221618914600834Healing evaluationChronic renal failurePure-tone audiometryDistortion-product otoacoustic emission
collection DOAJ
language English
format Article
sources DOAJ
author Evis Bendo
Margarita Resuli
Spiros Metaxas
spellingShingle Evis Bendo
Margarita Resuli
Spiros Metaxas
Hearing evaluation in patients with chronic renal failure
Journal of Acute Disease
Healing evaluation
Chronic renal failure
Pure-tone audiometry
Distortion-product otoacoustic emission
author_facet Evis Bendo
Margarita Resuli
Spiros Metaxas
author_sort Evis Bendo
title Hearing evaluation in patients with chronic renal failure
title_short Hearing evaluation in patients with chronic renal failure
title_full Hearing evaluation in patients with chronic renal failure
title_fullStr Hearing evaluation in patients with chronic renal failure
title_full_unstemmed Hearing evaluation in patients with chronic renal failure
title_sort hearing evaluation in patients with chronic renal failure
publisher Wolters Kluwer Medknow Publications
series Journal of Acute Disease
issn 2221-6189
publishDate 2015-03-01
description Objective: To evaluate hearing threshold and the severity of hearing loss at different frequencies in patients with chronic renal failure (CRF), and to analyze the role of duration of disease on hearing threshold in patients of CRF by measuring pure-tone audiometry (PTA) and distortion-product otoacoustic emission (DPOAE). Methods: There were analysed 61 subjects (122 ears) from which 12 were patients starting hemodialise (A), 24 subjects were patients undergoing hemodialise over a year (B), 15 subjects were patients undergoing conservative treatment (C) and 10 controls (D). We did hearing evaluation by testing them using tympanometry, PTA and DPOAEs. Other parameters (blood pressure, body weight, blood chemistries) were also evaluated. Results: It was found a severe high-frequency hearing loss among patients with CRF comparing to the control group. Duration on haemodialysis treatment does not seem to have a significant impact on the incidence of hearing loss, although the method of treatment may influence the impact of the disease on hearing. Hearing loss among patients with CRF seemed to deteriorate further a year after the first evaluation. Conclusions: DPOAE raised the percentages of detection of SNHL indicating that it is a better technique than the conventional PTA for evaluation of hearing acuity.
topic Healing evaluation
Chronic renal failure
Pure-tone audiometry
Distortion-product otoacoustic emission
url http://www.sciencedirect.com/science/article/pii/S2221618914600834
work_keys_str_mv AT evisbendo hearingevaluationinpatientswithchronicrenalfailure
AT margaritaresuli hearingevaluationinpatientswithchronicrenalfailure
AT spirosmetaxas hearingevaluationinpatientswithchronicrenalfailure
_version_ 1725928509144039424